Application of TRAF6 inhibitor as and/or in preparation of ferroptosis inducer
A technology of inhibitors and inducers, applied in the field of application of TRAF6 inhibitors as and/or in the preparation of ferroptosis inducers, capable of solving problems such as unreported
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0133] The preparation method of the reagent or reagent in this embodiment is as follows:
[0134] Winter Lingnin Storage Hydram: Winter Trancin powder is placed in a sterile centrifugal tube with electronics, then adding dimethyl sulfoxide (DMSO), formulated a concentration of 20 mm.
Embodiment 1
[0135] Example 1 TRAF6 inhibitor induced iron death
[0136] (1) Cell transfection: H358 cells with 8 × 10 4 The density of / ml is inoculated in a 12-well plate, and the cells were cultured to 70% to 80% cell fusion per well for transfection: TRAF6-siRNA or NC-siRNA was carried out using Lipofectamine 2000 (Invitrogen, USA). Transfection (negative control NC-siRNA and Traf6-siRNA) were purchased in Sangonbiotech (Shanghai, China), of which traf6-siRNA sequence is TggattctCactGGCAAA, SEQ ID NO: 1, SEQ ID NO: 1 in t equivalent to U), NC- The final concentration of siRNA and TRAF6-siRNA was 10 nm; finally analyzed the expression level of the target protein in a cell transfected 48h, and the successful transfected cells were selected for subsequent experiments.
[0137] (2) Western Blot Detection TRAF6, C-MYC, Cyclin D1, GPX4, SLC7A11, FTH1 expression: cell protein is successfully transfected with RIPA cleavage liquid, collecting cellular protein; collected protein Samples were subje...
Embodiment 2
[0141] Example 2 Winter Ling Graphicine oridonin as Traf6 inhibitor induced iron death
[0142] (1) PD-L1 fluorescent antibody detection intracellular PD-L1 content: H358 cells in 1 × 10 5 / ml density in a 12-well plate, per well volume is 1 mL, and in 5% CO 2 The 37 ° C incubator was cultured overnight, and the second day was processed: 1) Divided into a blank control group (CONTROL) and the Winter Lingnin group (the final concentration of 2.5, 5, 10 μm respectively); and 2) Divided into blank control group (Control), gamma interferon (IFN-γ, final concentration of 20 ng / ml) group and IFN-γ (final concentration of 20 ng / ml) + Winter Lingnin (Oridonin, final concentration) The 10 μm group was administered for administration, and each treatment was treated with three complex apertures, and the cells were incubated with the PD-L1 fluorescent antibody (BioLegend, 393606) in a fridge in the 4 degree refrigerator; finally purified with PBS Cells, resuspended cells After detecting ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com